The attribution substrate for AI-generated biotech research and discovery.
As AI contributes to drug discovery, genomic analysis, and experimental design, the question of attribution — who or what produced a result — becomes legally and scientifically critical. This is the canonical .ai address for that infrastructure.
Matched pair · sold together
Held and transacted as one position. A matched .ai + .com pair forecloses its own most common confusable — one coordinate, not two names.
The set
Part of the Biotech resolution surface.
6 of 7 primitives held for biotech. The unheld primitives complete the row.
Held as a matched pair — the Biotech row holds 4 matched pairs across the seven primitives.
See the full Biotech opportunity →Coordinated sets this position belongs to — the coverage it extends. Counts are the live cluster size in the graph.
Primary home
Also appears in
Architectural context
Biotech · Vertical-Specific · 2 compound moats. Architectural surface: Attribution.
Layer position: Cross-cutting
Why this is canonical
'Attribution' in biotech intersects intellectual property (inventorship for AI-generated patents), scientific publication integrity, and regulatory provenance. The .ai TLD signals that this is infrastructure for the AI-native era of biotech.
Where it fits
A few directions this coordinate opens —
Illustrative, not exhaustive — held as a transferable canonical position, open to the buyer's own use.